Related Experiment Video
Updated: Mar 17, 2026
10:02
Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
15.6K
Insights
Cervical adenopathies present in various forms, including acute, subacute, unilateral, bilateral, pyogenic, and nonpyogenic. Penicillin effectively treats nonstaphylococcal pyogenic adenitis.
Area of Science:
- Medicine
- Infectious Diseases
- Oncology
Background:
- Cervical adenopathies encompass a wide spectrum of conditions, varying in onset, laterality, etiology, and nature.
- These conditions can range from acute to subacute presentations and from benign to malignant processes.
Purpose of the Study:
- To outline the diverse clinical presentations of cervical adenopathies.
- To identify the primary therapeutic agent for nonstaphylococcal pyogenic adenitis.
Main Methods:
- Literature review of cervical adenopathies.
- Clinical guidelines for infectious adenitis.
Main Results:
- Cervical adenopathies are classified based on clinical and etiological factors.
- Penicillin is established as the first-line treatment for nonstaphylococcal pyogenic adenitis.
Conclusions:
- Understanding the varied nature of cervical adenopathies is crucial for diagnosis.
- Penicillin remains the drug of choice for specific types of bacterial cervical adenitis.
Abstract:
Cervical adenopathies may be acute or subacute, unilateral or bilateral, pyogenic or nonpyogenic, malignant or nonmalignant. Penicillin is the drug of choice for treating all nonstaphylococcal pyogenic adenitis.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
360
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
313
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
645
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
645
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
423
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
423
01:29Drug Dosing: Infants and Children
692
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
692
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
308
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
308